Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK / HO ‐1 pathway activation
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Wei-En Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) has a high recurrence rate and poor prognosis. Hispolon, a polyphenolic compound with antiviral, antioxidant, and anticancer activities, is a potential chemotherapy agent. However, few studies have investigated the anti‐cancer mechanism of hispolon in oral cancer. This present study used the cell viability assay, clonogenic assay, fluorescent nuclear staining, and flow cytometry assay to analyse the apoptosis‐inducing effects of hispolon in OSCC cells. After hispolon treatment, the apoptotic initiators, cleaved caspase‐3, −8, and − 9, were upregulated, whereas the cellular inhibitor of apoptosis protein‐1 (cIAP1) was downregulated. Furthermore, a proteome profile analysis using a human apoptosis array revealed the overexpression of heme oxygenase‐1 (HO‐1) by hispolon, which was determined to be involved in caspase‐dependent apoptosis. Moreover, cotreatment with hispolon and mitogen‐activated protein kinase (MAPK) inhibitors revealed that hispolon induces apoptosis in OSCC cells through activation of the c‐Jun N‐terminal kinase (JNK) pathway and not the extracellular signal‐regulated kinase (ERK) or p38 pathway. These findings indicate that hispolon may exert an anticancer effect on oral cancer cells by upregulating HO‐1 and inducing caspase‐dependent apoptosis by activating the JNK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
- Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan.
- Oral cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
ORCID-Profile: Shun-Fa Yang
Förderung
- Chung Shan Medical University Hospital
Zitieren
APA
Yang, W. E., Chen, Y. T., Su, C. W., Chen, M. K., Yeh, C. M., Chen, Y. L., Tsai, M. Y., Yang, S. F., & Lin, C. W. (2023). Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK / HO ‐1 pathway activation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17729
Vancouver
Yang WE, Chen YT, Su CW, Chen MK, Yeh CM, Chen YL, et al. Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK / HO ‐1 pathway activation. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17729
BibTeX
@article{Yang2023,
author = {Yang, Wei-En and Chen, Yi-Tzu and Su, Chun-Wen and Chen, Mu-Kuan and Yeh, Chia-Ming and Chen, Yen-Lin and Tsai, Meng-Ying and Yang, Shun-Fa and Lin, Chiao-Wen},
title = {Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK / HO ‐1 pathway activation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17729}
}
EUVIMED